Explore
Trendline
Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy
Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy
Read More
Trendline
Innate Pharma Reports Progress in Immunotherapy Pipeline and Financial Results for Q1 2026
Innate Pharma Reports Progress in Immunotherapy Pipeline and Financial Results for Q1 2026
Read More
Trendline
Innate Pharma Reports Q1 2026 Business Update and Financial Results
Innate Pharma Reports Q1 2026 Business Update and Financial Results
Read More
Trendline
PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials
PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials
Read More
Trendline
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Read More
Trendline
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Read More
Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Read More
Trendline
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Read More
Trendline
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Read More
Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Read More
Trendline
Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates
Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates
Read More
Trendline
Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026
Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026
Read More
